Sponsored by


Drug that treats COVID with nearly 90% efficacy gets FDA green light

The first pill to treat COVID-19 received approval from U.S. regulators on Wednesday, giving way to a new pandemic therapy in treating patients who are at high risk of being hospitalized or dying that can be deployed to adults and children ages 12 and older. ... Read more»

Científicos dicen que una píldora diaria para tratar COVID estaría a meses de distancia

Una familia de Seattle, Washington juega un papel en el desarrollo de unas pastillas diarias que pueden combatir los síntomas de COVID temprano después de una diagnóstico positivo y también limitar la transmisión del virus. ... Read more»

A daily pill to treat COVID could be just months away, scientists say

Clinical trials are underway at the Fred Hutch cancer research center that’s part of an international effort to test an antiviral treatment that could halt COVID early in its course.... Read more»

FactCheck: Social media post on use of ivermectin for refugees lacks context

The Centers for Disease Control and Prevention recommends the use of ivermectin as a treatment for arriving refugees to treat parasitic infections, but a social media post references the CDC guidance without accurately explaining the reason why refugees are given the drug. ... Read more»